Private equity firm to buy Auslab owner Citadel Group for $503m

The directors of ASX-listed Citadel Group are supporting a bid from private equity firm Pacific Equity Partners (PEP) to buy out the company for $503.1 million.

Citadel Group's healthcare division Citadel Health markets the Evolution laboratory information system, previously known as Auslab, along with the Charm oncology solution.

Citadel recently received an extension to its decades-long contract with Queensland Health for Auslab following the cancellation of the $64 million laboratory information system replacement project with Sunquest. It is also used by NSW Health Pathology and several large health services in Victoria.

Posted in Australian eHealth

Tags: Citadel Health

Add comment

Please note comments of a self-promotional nature are likely to be deleted.

Security code
Refresh

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2020 Pulse+IT Magazine
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.